ArticleCureus2026
Recurrent Lower Extremity Pseudocellulitis in a Liver Transplant Recipient: Suspected Tacrolimus-Associated Drug Eruption.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutaneous drug eruptions can closely mimic cellulitis, creating a diagnostic challenge in transplant recipients receiving multiple potentially contributory medications. We report recurrent lower-extremity pseudocellulitis in a 55-year-old liver transplant recipient whose clinical course raised suspicion for a tacrolimus-associated drug eruption. Over 11 months, she was hospitalized 10 times and received multiple therapeutic and prophylactic antimicrobial regimens without sustained improvement. Repeated microbiologic studies, including bacterial, fungal, and acid-fast bacillus tissue cultures, were negative. Dermatologic evaluation and skin biopsy demonstrated a superficial and deep perivascular, perieccrine, and focally interstitial inflammatory infiltrate without evidence of infection or vasculitis. The relapsing course, negative microbiologic evaluation, and nonspecific inflammatory biopsy findings favored a noninfectious process. Tacrolimus was considered one possible contributor based on the reported onset after transplantation and recurrence during continued exposure, although uncertain latency and concomitant antimicrobial exposure limited causal attribution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.